A Proposed Revision of the Stepwise Treatment Algorithm in Asthma.

Szczegóły

Tytuł:: A Proposed Revision of the Stepwise Treatment Algorithm in Asthma.
Autorzy:: Beasley R; Medical Research Institute of New Zealand Wellington New Zealand.; Victoria University of Wellington Wellington, New Zealand.; Capital & Coast District Health Board Wellington, New Zealand.
Bruce P; Medical Research Institute of New Zealand Wellington New Zealand.
Hatter L; Medical Research Institute of New Zealand Wellington New Zealand.; Imperial College London London, United Kingdom.
Braithwaite I; Medical Research Institute of New Zealand Wellington New Zealand.
Semprini A; Medical Research Institute of New Zealand Wellington New Zealand.
Kearns C; Medical Research Institute of New Zealand Wellington New Zealand.
Weatherall M; Capital & Coast District Health Board Wellington, New Zealand.; University of Otago Wellington, Wellington New Zealand.
Pavord ID; University of Oxford, Oxford, United Kingdom.
Źródło:: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Jul 01; Vol. 204 (1), pp. 100-103.
Typ publikacji:: Letter
Język:: English
Imprint Name(s):: Publication: 2000- : New York, NY : American Thoracic Society
Original Publication: New York, NY : American Lung Association, c1994-
MeSH Terms:: Algorithms*
Anti-Asthmatic Agents/*standards
Anti-Asthmatic Agents/*therapeutic use
Asthma/*drug therapy
Practice Guidelines as Topic/*standards
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Female ; Humans ; Male ; Middle Aged ; Young Adult
References:: JAMA. 2018 Apr 10;319(14):1485-1496. (PMID: 29554195)
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1471-1477. (PMID: 30645143)
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1480-1487. (PMID: 31905013)
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):751-8. (PMID: 25439367)
Eur Respir J. 2020 Sep 10;56(3):. (PMID: 32430423)
Lancet. 2018 Jan 27;391(10118):350-400. (PMID: 28911920)
N Z Med J. 2020 Jun 26;133(1517):73-99. (PMID: 32595223)
Lancet Respir Med. 2021 Feb;9(2):149-158. (PMID: 33010810)
Eur Respir J. 2020 Jan 9;55(1):. (PMID: 31919194)
Lancet Respir Med. 2021 Jan;9(1):57-68. (PMID: 32916135)
Substance Nomenclature:: 0 (Anti-Asthmatic Agents)
Entry Date(s):: Date Created: 20210331 Date Completed: 20210913 Latest Revision: 20210915
Update Code:: 20240104
PubMed Central ID:: PMC8437115
DOI:: 10.1164/rccm.202101-0224LE
PMID:: 33789069
: Opinia redakcyjna

Informacja